NCT02402296View on ClinicalTrials.gov

Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Localized Aggressive Periodontitis
Interventions
DRUG

β-1,3/1,6-D-glucan

15 patients (in group II) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of β-1,3/1,6-D-glucan oral supplementation for 40 days.

OTHER

Placebo

15 patients (in group I) suffering from localized aggressive periodontitis followed a strict plaque control program (within two weeks); followed by a systemic course of placebo capsules oral supplementation for 40 days.

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT02402296 - Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis | Biotech Hunter | Biotech Hunter